ENDPOINTS

Former Tome CEO joins Flagship startup; NGM Bio chief steps down as restructuring takes effect

Flagship Pioneering has recruited Rahul Kakkar to lead its genetics-based drug discovery startup Quotient Therapeutics. Kakkar was most recently CEO of Tome Biosciences, a high-profile gene editing company that launched with ...

May 2, 2025 - 12:04
 0
Former Tome CEO joins Flagship startup; NGM Bio chief steps down as restructuring takes effect
Flagship Pioneering has recruited Rahul Kakkar to lead its genetics-based drug discovery startup Quotient Therapeutics. Kakkar was most recently CEO of Tome Biosciences, a high-profile gene editing company that launched with ...
Read More

Tags:

Previous Article

Self-driving cars can tap into 'AI-powered social network' to talk to each other...

Next Article

‘Irreplaceable habitat’: planning bill raises fears for England’s chalk streams

Related Posts

Experts refute RFK Jr.'s claim that placebo-controlled trials for vaccines are new

Experts refute RFK Jr.'s claim that placebo-controlled ...

May 1, 2025  0

Exclusive: Axiom raises $15M to build AI models for drug toxicity

Exclusive: Axiom raises $15M to build AI models for dru...

Apr 28, 2025  0

AbbVie eyes $10B US expansion amid sector-specific tariff threat

AbbVie eyes $10B US expansion amid sector-specific tari...

Apr 25, 2025  0